Medicine
Diuril 250 mg/5 mL oral suspension
Diuril 250 mg/5 mL oral suspension is a prescription medicine containing Chlorothiazide for oral use, marketed by Salix Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Storage DIURIL (chlorothiazide) Oral Suspension: Keep container tightly closed.
Key facts
- Active ingredient (INN)
- Chlorothiazide
- Brand
- Diuril
- Strength
- 250 mg/5 mL
- Dosage form
- Oral suspension
- Route
- Oral
- Packs
- 1 bottle
- Marketing authorisation holder
- Salix Pharmaceuticals
- Manufacturer
- Salix Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Storage DIURIL (chlorothiazide) Oral Suspension: Keep container tightly closed.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C03AA04 Chlorothiazide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 February 1962
- Identifiers
- RxCUI 213439, 309198DailyMed set ID bd936e35-1af8-42da-bcc0-f22489d68574NDC 65649-311Application NDA011870
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 237 mL in 1 bottle | 65649-311-12 | Salix Pharmaceuticals | 15 February 1962 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 4 September 1958 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Chlorothiazide
Clinical summary
Chlorothiazide is a thiazide diuretic indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy, among other approved uses. MedsAcross supplies Chlorothiazide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ChlorothiazideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- DIURIL prescribing information (Salix Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Diuril 250 mg/5 mL oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.